Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways.

Inhibition of δ-opioid receptors induces brain glioma cell apoptosis through the mitochondrial and protein kinase C pathways.

Efficacy of ribavirin against malignant glioma cell lines.

Silencing of protein kinase D2 induces glioma cell senescence via p53-dependent and -independent pathways.

Response of malignant glioma cell lines to epidermal growth factor and platelet-derived growth factor in a serum-free medium.

Targeting of glioblastoma cell lines and glioma stem cells by combined PIM kinase and PI3K-p110α inhibition.

Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro.

Failure of betamethasone to alter the radiation response of two cultured human glioma cell-lines.

Activation of Nrf2 pathways correlates with resistance of NSCLC cell lines to CBP501 in vitro.

MicroRNAs and cell cycle of malignant glioma.

Phosphorylation of pyruvate kinase and glycolytic metabolism in three human glioma cell lines.

Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.

Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell lines.

AKT activation controls cell survival in response to HDAC6 inhibition.

Bryostatin-1 causes radiosensitization of BMG-1 malignant glioma cells through differential activation of protein kinase-Cδ not evident in the non-malignant AA8 fibroblasts.

Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition.

Activation of autophagic pathways is related to growth inhibition and senescence in cutaneous squamous cell carcinoma.

G protein-coupled receptor kinase 6 is overexpressed in glioma and promotes glioma cell proliferation.

T cell antigen receptor activation pathways: the tyrosine kinase connection.

Response gene to complement 32 protein promotes macrophage phagocytosis via activation of protein kinase C pathway.

Mechanism of chemoresistance against tyrosine kinase inhibitors in malignant glioma.

Expression of the GABAB receptor in Xenopus oocytes and inhibition of the response by activation of protein kinase C.

Inhibition of p38 mitogen-activated protein kinase ameliorates radiation-induced ototoxicity in zebrafish and cochlea-derived cell lines.

Effects of tetrandrine on glioma cell malignant phenotype via inhibition of ADAM17.

Light-controlled inhibition of malignant glioma by opsin gene transfer.

Suggest Documents

Inhibition of δ-opioid receptors induces brain glioma cell apoptosis through the mitochondrial and protein kinase C pathways.

Efficacy of ribavirin against malignant glioma cell lines.

Silencing of protein kinase D2 induces glioma cell senescence via p53-dependent and -independent pathways.

Response of malignant glioma cell lines to epidermal growth factor and platelet-derived growth factor in a serum-free medium.

Targeting of glioblastoma cell lines and glioma stem cells by combined PIM kinase and PI3K-p110α inhibition.

Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro.

Failure of betamethasone to alter the radiation response of two cultured human glioma cell-lines.

Activation of Nrf2 pathways correlates with resistance of NSCLC cell lines to CBP501 in vitro.

MicroRNAs and cell cycle of malignant glioma.

Phosphorylation of pyruvate kinase and glycolytic metabolism in three human glioma cell lines.

Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.

Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell lines.

AKT activation controls cell survival in response to HDAC6 inhibition.

Bryostatin-1 causes radiosensitization of BMG-1 malignant glioma cells through differential activation of protein kinase-Cδ not evident in the non-malignant AA8 fibroblasts.

Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition.

Activation of autophagic pathways is related to growth inhibition and senescence in cutaneous squamous cell carcinoma.

G protein-coupled receptor kinase 6 is overexpressed in glioma and promotes glioma cell proliferation.

T cell antigen receptor activation pathways: the tyrosine kinase connection.

Response gene to complement 32 protein promotes macrophage phagocytosis via activation of protein kinase C pathway.

Mechanism of chemoresistance against tyrosine kinase inhibitors in malignant glioma.

Expression of the GABAB receptor in Xenopus oocytes and inhibition of the response by activation of protein kinase C.

Inhibition of p38 mitogen-activated protein kinase ameliorates radiation-induced ototoxicity in zebrafish and cochlea-derived cell lines.

Effects of tetrandrine on glioma cell malignant phenotype via inhibition of ADAM17.

Light-controlled inhibition of malignant glioma by opsin gene transfer.

Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways.

Recommend Documents

Follow Us